Navigation Links
GEN reports biomanufacturers target a fully disposable process stream
Date:3/5/2009

New Rochelle, NY, March 4, 2009--The disposable bioprocessing market has moved far beyond plastic bags for buffer preparation toward a range of products for cell culture and upstream and downstream operations, reports Genetic Engineering & Biotechnology News (GEN). Increasing numbers of biomanufacturing experts now believe that a completely disposable bioprocess stream is feasible and even within reach, according to the March 1 issue of GEN (www.genengnews.com/articles/chitem.aspx?aid=2818).

"It should come as no surprise that bioprocess disposables are rapidly gaining in popularity within the industry as their use minimizes expensive validation studies and avoids many costly sterilization and cleaning procedures," says John Sterling, Editor in Chief of GEN.

The largest hurdles remaining relate to disposable technology development in the areas of biosensors and chromatographic purification. Progress is being made in these areas, though, and the discussions have shifted from the challenges to an emphasis on the opportunities disposable products provide, especially in terms of ease of use, flexibility, maximizing infrastructure utilization, in addition to cost savings, environmental impact.

For example, GE Healthcare offers its ReadyMate line of genderless disposable connectors. By eliminating the need to stock both male and female connectors, inventories can be reduced by half, according to the company.

Pall's Allegro line of disposable products for small- to large-scale processing includes Kleenpak Nova capsule filters. Single-use Kleenpak Connectors, each composed of a male and a female connector, are used to link two separate presterilized fluid pathways. The company's Allegro 2-D biocontainers range in size from 50 mL to 50 L, while Allegro 3-D biocontainers and accompanying front-loading stainless steel totes are available in 100 L, 200 L, and
'/>"/>

Contact: John Sterling
jsterling@genengnews.com
914-740-2196
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1 2

Related biology news :

1. BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008
2. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
3. GEN reports on strategies to overcome blood-brain barrier
4. GEN reports on growing reliance on microfluidics technology
5. Cytori reports benefit of adipose-derived regenerative cells in spinal disc model
6. GEN reports growing focus on PI3-kinase pathway in cancer research
7. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
8. Orchid Cellmark Reports Third Quarter 2008 Financial Results
9. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
10. Synaptics Reports Record Results for First Quarter of Fiscal 2009
11. GEN reports on novel tools for deciphering biological networks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)...  For more than four decades, AUVSI,s Unmanned ... premier worldwide event for the unmanned land, sea, and ... for any local, national, or trade news organization interested ... and current applications of unmanned technologies. The conference will ... billion industry, and how it will soon impact the ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... be effective in treating kidney disease, report scientists at the ... the online edition of the Proceedings of the National Academies ... drug is rapamycin, also called sirolimus, and is currently used ... new, transplanted kidney. , Over 600,000 people in the ...
... lure of chocolate or the bitter taste of strychnine would ... as to be hard-wired into the brain. Indeed, in studies ... colleagues reported in the January 19, 2006, issue of Neuron ... they said, favor a model for taste encoding in the ...
... is developing a novel gene therapy aimed at selectively ... development of Parkinson's disease. , The gene therapy, described ... Neurology, was designed by Martha Bohn and her laboratory ... , Bohn is Medical Research Council Professor and director ...
Cached Biology News:Scientists discover that widely available drug also helps fight kidney disease 2Scientists discover that widely available drug also helps fight kidney disease 3How taste response is hard-wired into the brain 2Gene therapy 'turns off' mutation linked to Parkinson's disease 2
(Date:5/27/2015)... Calif. , May 27, 2015  Two years ... biotech professionals, hackers and citizen scientists, Oakland ... $30,000 crowdfunding campaign promoting its mission to democratize science ... Temescal District. ... Based out of ...
(Date:5/27/2015)... Mass. , May 27, 2015  RXi ... company focused on discovering and developing innovative therapies ... today provided an update on the status of the ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ... were 3,085 and 21 shares of Series A ...
(Date:5/26/2015)... BELLINGHAM, Washington, USA (PRWEB) May 26, 2015 ... a formal partnership with the Max Planck Society ... Extreme and Quantum Photonics. The center will link two ... of photonics, and will be only the third Max ... SPIE, the international society for optics and photonics, ...
(Date:5/26/2015)... 26, 2015 Innovacyn, a leader ... the human and animal health industries, announced today ... Innovators of Agriculture College Scholarship Award. The scholarship ... exhibits a passionate commitment to the agriculture industry ... year’s winners, Alexis Pedrow from Anderson County Jr/Sr ...
Breaking Biology Technology:East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 2RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 2Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 3
... 2011 One of the hot topics among healthcare ... requirements in the coming years. Community oncologists, practice administrators ... Use requirements and how these could affect community oncology ... 1 p.m. EDT (10 a.m. PDT) on Thursday, July ...
... we know them, from televisions to computers, depend on conducting ... to pocket sized communications devices and microchips that can fit ... in big demand. Now, Prof. Eran Rabani of Tel ... Sackler Faculty of Exact Sciences, in collaboration with Profs. Uri ...
... Biotechnology, Inc., (OTC: CSBR): Highlights: ... of 41% to $6.9 million Net loss of $3.8 ... Net loss of ($0.10) per share; net loss excluding ... million at year end Annual 2011 Financial ...
Cached Biology Technology:Medicare HIT Incentive Update for the Oncology Practice - Free Educational Webinar 2Medicare HIT Incentive Update for the Oncology Practice - Free Educational Webinar 3Conducting energy on a nano scale 2Conducting energy on a nano scale 3Champions Oncology Reports Full Year 2011 Financial Results 2Champions Oncology Reports Full Year 2011 Financial Results 3Champions Oncology Reports Full Year 2011 Financial Results 4Champions Oncology Reports Full Year 2011 Financial Results 5Champions Oncology Reports Full Year 2011 Financial Results 6
... Polymerase is a thermostable recombinant DNA polymerase, ... extension and other molecular biology applications. Red ... easy and quick identification of reactions to ... of complete mixing. The inert dye has ...
... immuncapture enzyme-activity assay based on measurenment of ... monoclonal antibody coated microtiter plate. The procedure ... samples or controls, 2nd enzyme reaction) ... is intended for the determination of human ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Biology Products: